Legal Representation
Attorney
Daniel R. Frijouf
USPTO Deadlines
Next Deadline
37 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
September 05, 2025
Extension Available
Until September 05, 2024
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 4, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 4, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 28, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 25, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Oct 25, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Oct 25, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Oct 25, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Oct 7, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 7, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 5, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 13, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 12, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 9, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Apr 9, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Apr 9, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Apr 9, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Apr 9, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Apr 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 5, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 5, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 11, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 11, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 21, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 5, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 5, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 5, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 5, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 5, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 2, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 1, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 1, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 1, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 1, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 2, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 2, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 2, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 2, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 26, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 26, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 16, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 16, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 16, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 11, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
Biological preparations comprising exosomes for use in scientific research, industry and science; Biological preparations comprising exosomes for use in the manufacture of pharmaceuticals for treating wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for scientific and medical research use; Cord blood for scientific and medical research use; Stem cells for research and scientific purposes
Class 005
Cell parts in the nature of exosomes for medical purposes; biological preparations comprising exosomes for the treatment of wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for medical purposes; blood plasma; cord blood for medical purposes; stem cells for medical purposes
Class 044
Medical services, namely, infusion therapy services; Medical services, namely, cord blood infusion services, stem cell infusion services; Medical services, namely, stem cell transplantation, stem cell therapy and stem cell treatment services; Blood, organ, and tissue bank services for human blood, human umbilical cord blood, human umbilical cord blood stem cells, mesenchymal stem cells, human menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; collection and preservation of human blood, menstrual blood, and umbilical cord blood, for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; Collection of umbilical cord stem cells, mesenchymal stem cells, menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use
Additional Information
Translation
The English translation of the word "CELLE" in the mark is "THE ONE".
Classification
International Classes
001
005
044